Robert K. Evans

3.8k total citations
44 papers, 1.7k citations indexed

About

Robert K. Evans is a scholar working on Molecular Biology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Robert K. Evans has authored 44 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 7 papers in Epidemiology and 6 papers in Infectious Diseases. Recurrent topics in Robert K. Evans's work include DNA and Nucleic Acid Chemistry (8 papers), RNA Interference and Gene Delivery (6 papers) and Advanced biosensing and bioanalysis techniques (6 papers). Robert K. Evans is often cited by papers focused on DNA and Nucleic Acid Chemistry (8 papers), RNA Interference and Gene Delivery (6 papers) and Advanced biosensing and bioanalysis techniques (6 papers). Robert K. Evans collaborates with scholars based in United States and Australia. Robert K. Evans's co-authors include Boyd E. Haley, C. Russell Middaugh, De‐Min Zhu, Danilo R. Casimiro, David B. Volkin, Mary Sue Colemán, Donna L. Montgomery, Priyanka Desai, Jie Tang and William F. McDonald and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Biochemistry.

In The Last Decade

Robert K. Evans

40 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert K. Evans United States 21 948 423 358 302 282 44 1.7k
Michel Vandenbranden Belgium 29 1.7k 1.8× 573 1.4× 149 0.4× 314 1.0× 216 0.8× 66 2.4k
Michael Chastain United States 16 934 1.0× 557 1.3× 387 1.1× 404 1.3× 174 0.6× 20 1.8k
Gary Fujii United States 15 691 0.7× 627 1.5× 213 0.6× 184 0.6× 205 0.7× 29 1.4k
Carl J. Wheeler United States 19 996 1.1× 330 0.8× 181 0.5× 319 1.1× 224 0.8× 27 1.5k
Daniel C. Stein United States 26 865 0.9× 236 0.6× 308 0.9× 465 1.5× 184 0.7× 104 2.3k
Hiroshi Takaku Japan 27 2.2k 2.3× 506 1.2× 627 1.8× 392 1.3× 493 1.7× 263 3.4k
Lennart Åkerblom Sweden 21 527 0.6× 670 1.6× 397 1.1× 95 0.3× 316 1.1× 42 1.5k
Maria E. Baca‐Estrada Canada 23 538 0.6× 585 1.4× 320 0.9× 309 1.0× 271 1.0× 48 1.5k
Rinaldo Zurbriggen Switzerland 28 788 0.8× 874 2.1× 664 1.9× 161 0.5× 422 1.5× 58 2.0k
Christopher M. Wiethoff United States 26 1.7k 1.8× 403 1.0× 429 1.2× 967 3.2× 427 1.5× 37 2.6k

Countries citing papers authored by Robert K. Evans

Since Specialization
Citations

This map shows the geographic impact of Robert K. Evans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert K. Evans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert K. Evans more than expected).

Fields of papers citing papers by Robert K. Evans

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert K. Evans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert K. Evans. The network helps show where Robert K. Evans may publish in the future.

Co-authorship network of co-authors of Robert K. Evans

This figure shows the co-authorship network connecting the top 25 collaborators of Robert K. Evans. A scholar is included among the top collaborators of Robert K. Evans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert K. Evans. Robert K. Evans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mach, Henryk, et al.. (2010). The Use of Flow Cytometry for the Detection of Subvisible Particles in Therapeutic Protein Formulations. Journal of Pharmaceutical Sciences. 100(5). 1671–1678. 35 indexed citations
2.
Woolley, Claire, et al.. (2009). Congenital lumbar hernia: Figure 1. Archives of Disease in Childhood Fetal & Neonatal. 94(5). F327–F327. 4 indexed citations
3.
Huleatt, James W., Valerian Nakaar, Priyanka Desai, et al.. (2007). Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellin. Vaccine. 26(2). 201–214. 318 indexed citations
4.
Evans, Robert K., et al.. (2005). Effect of pH and ionic strength on the physical stability of adenovirus type 5. Journal of Pharmaceutical Sciences. 95(2). 237–247. 67 indexed citations
5.
Altaras, Nedim Emil, John Auniņš, Robert K. Evans, et al.. (2005). Production and Formulation of Adenovirus Vectors. Advances in biochemical engineering, biotechnology. 99. 193–260. 65 indexed citations
6.
Evans, Robert K., De‐Min Zhu, Danilo R. Casimiro, et al.. (2004). Characterization and biological evaluation of a microparticle adjuvant formulation for plasmid DNA vaccines. Journal of Pharmaceutical Sciences. 93(7). 1924–1939. 20 indexed citations
7.
Evans, Robert K., Denise K. Nawrocki, Lynne A. Isopi, et al.. (2004). Development of stable liquid formulations for adenovirus-based vaccines. Journal of Pharmaceutical Sciences. 93(10). 2458–2475. 122 indexed citations
8.
Evans, Robert K., et al.. (2003). Clinical Pearls: Neonatal Breast Mass. Academic Emergency Medicine. 10(3). 269–270. 6 indexed citations
9.
Evans, Robert K., et al.. (2000). Evaluation of Degradation Pathways for Plasmid DNA in Pharmaceutical Formulations via Accelerated Stability Studies. Journal of Pharmaceutical Sciences. 89(1). 76–87. 100 indexed citations
10.
Wang, Su, Xu Liu, Karen L. Fisher, et al.. (2000). Enhanced type I immune response to a hepatitis B DNA vaccine by formulation with calcium- or aluminum phosphate. Vaccine. 18(13). 1227–1235. 69 indexed citations
11.
Ulmer, Jeffrey B., Corrille M. DeWitt, Michael Chastain, et al.. (1999). Enhancement of DNA vaccine potency using conventional aluminum adjuvants. Vaccine. 18(1-2). 18–28. 113 indexed citations
12.
Middaugh, C. Russell, Robert K. Evans, Donna L. Montgomery, & Danilo R. Casimiro. (1998). Analysis of Plasmid DNA from a Pharmaceutical Perspective. Journal of Pharmaceutical Sciences. 87(2). 130–146. 126 indexed citations
13.
Roseman, N A, Robert K. Evans, Erica L. Mayer, Mauro Rossi, & Mary B. Slabaugh. (1996). Purification and Characterization of the Vaccinia Virus Deoxyuridine Triphosphatase Expressed in. Journal of Biological Chemistry. 271(38). 23506–23511. 15 indexed citations
14.
15.
Evans, Robert K., et al.. (1991). Contacts between 5 S DNA and Xenopus TFIIIA identified using 5-azido-2'-deoxyuridine-substituted DNA.. Journal of Biological Chemistry. 266(25). 16478–16484. 14 indexed citations
16.
Evans, Robert K. & Mary Sue Colemán. (1989). Photoaffinity labeling of terminal deoxynucleotidyl transferase. 1. Active site directed interactions with 8-azido-2'-deoxyadenosine 5'-triphosphate. Biochemistry. 28(2). 707–712. 12 indexed citations
17.
Evans, Robert K., Carol M. Beach, & Mary Sue Colemán. (1989). Photoaffinity labeling of terminal deoxynucleotidyl transferase. 2. Identification of peptides in the nucleotide binding domain. Biochemistry. 28(2). 713–720. 23 indexed citations
18.
Evans, Robert K. & Boyd E. Haley. (1987). Synthesis and biological properties of 5-azido-2'-deoxyuridine 5'-triphosphate, a photoactive nucleotide suitable for making light-sensitive DNA. Biochemistry. 26(1). 269–276. 72 indexed citations
19.
Anderson, Donald O., et al.. (1966). Applications and enrolments at the Western medical schools: a study of medical matriculants for 1964.. PubMed. 95(26). 1368–74. 2 indexed citations
20.
Anderson, Donald O., et al.. (1965). THE PREMEDICAL STUDENT: HIS PROGRESS. A STUDY OF A COHORT OF PREMEDICAL STUDENTS AT THE UNIVERSITY OF BRITISH COLUMBIA.. PubMed. 92. 717–22. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michel Vandenbranden Breakdown of academic impact, for papers by Michael Chastain Breakdown of academic impact, for papers by Gary Fujii Breakdown of academic impact, for papers by Carl J. Wheeler Breakdown of academic impact, for papers by Daniel C. Stein Breakdown of academic impact, for papers by Hiroshi Takaku Breakdown of academic impact, for papers by Lennart Åkerblom Breakdown of academic impact, for papers by Maria E. Baca‐Estrada Breakdown of academic impact, for papers by Rinaldo Zurbriggen Breakdown of academic impact, for papers by Christopher M. Wiethoff
Rankless by CCL
2026